News

At baby's 2-month well visit, he'll receive a number of other essential immunizations, including RV (rotavirus), DTaP (diphtheria, tetanus and pertussis, which is also known as whooping cough), Hib ...
FDA accepts GSK's filing to extend Arexvy's RSV vaccine use to high-risk adults under 50, with a decision due in 2026.
Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...
The label expansion sought by GSK is a bid to compete with Pfizer and Moderna in the younger age groups of the RSV vaccine market. Pfizer’s Abrysvo and Moderna’s mRESVIA are both approved to prevent ...
The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...
The CDC's Vaccine Recommendations Draw Scrutiny Amid Controversial Changes** In a move that raises eyebrows, the Centers for Disease Control and Prevention (CDC) h ...
RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...
Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...
The new vaccine committee appointed by Secretary Robert F. Kennedy Jr. took minimal action in its first meeting.
It is a mistake to claim that there is not widespread research into the effectiveness of vaccines, especially those given to ...